TuHURA Biosciences (HURA) Other Non-Current Assets (2020 - 2026)

TuHURA Biosciences' (HURA) quarterly Other Non-Current Assets came in at $11.3 million in Q1 2026, up 33288.61% quarter-over-quarter from $33769.0 in Q4 2025.

TuHURA Biosciences (HURA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

TuHURA Biosciences' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $11.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $33769.0, changed 0.0% from the prior year.
  • Other Non-Current Assets rose to $11.3 million in Q1 2026 per HURA's latest filing, from $33769.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $11.3 million in Q1 2026 and bottomed at $33769.0 in Q4 2024.
  • The 4-year median for Other Non-Current Assets is $3.4 million (2022), against an average of $4.7 million.
  • Across the five-year window, Other Non-Current Assets jumped 104.76% in 2022 and changed 0.0% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $4.3 million in 2022, then plunged by 99.21% to $33769.0 in 2024, then changed by 0.0% to $33769.0 in 2025, then soared by 33288.61% to $11.3 million in 2026.
  • Per Business Quant, the three latest HURA Other Non-Current Assets figures stand at $11.3 million (Q1 2026), $33769.0 (Q4 2025), and $8.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.02 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 14.48 Mn
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - 11.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.28 Mn
Dec 31, 2025 33,769.00
Sep 30, 2025 8.26 Mn
Jun 30, 2025 8.26 Mn
Dec 31, 2024 33,769.00
Sep 30, 2022 4.30 Mn
Jun 30, 2022 2.60 Mn
Mar 31, 2022 2.60 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 2.10 Mn
Jun 30, 2021 1.60 Mn
Mar 31, 2021 2.10 Mn
Dec 31, 2020 2.60 Mn